Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.ncbi.nlm.nih.gov › pmc › articlesThrombocytopenia and Therapeutic Strategies after Allogeneic ...

   www.ncbi.nlm.nih.gov › pmc › articles

   2 mar 2022 · Thrombopoietin receptor agonists are currently available to stimulate platelet production. Some small retrospective studies have reported their potential efficacy in an allogeneic stem cell transplant setting, confirming good tolerability.

2. ashpublications.org › thehematologist › articleThrombocytopenia Post-transplantation: A Clinical Challenge in...

   ashpublications.org › thehematologist › article

   • Zapisane w pamięci cache

   10 kwi 2019 · Dr. Serena Marotta and colleagues describe utilizing eltrombopag specifically for persistent cytopenia and poor graft function in 12 patients at a single European center in this retrospective series. The treatment was started at a dose of 50 mg/d and uptitrated to 150 mg to increase response rates.

3. www.mdpi.com › 2077/0383/11-5 › 1364Thrombocytopenia and Therapeutic Strategies after Allogeneic ...

   www.mdpi.com › 2077/0383/11-5 › 1364

   • Zapisane w pamięci cache

   2 mar 2022 · Thrombopoietin receptor agonists are currently available to stimulate platelet production. Some small retrospective studies have reported their potential efficacy in an allogeneic stem cell transplant setting, confirming good tolerability.

4. www.clinical-lymphoma-myeloma-leukemia.com › article › S2152-2650(18)30585-8Day +100 Platelet Count Predicts Survival After Allogeneic ...

   www.clinical-lymphoma-myeloma-leukemia.com › article › S2152-2650(18)30585-8

   Recovery of platelet count by day 100 after hematopoietic stem-cell transplantation (HSCT) is affected by many factors and has been reported to be a predictor of overall survival (OS) in a variety of diseases and donor types.

5. www.nature.com › articles › s41409/022/01726-2Delayed platelet recovery and mortality after allogeneic stem...

   www.nature.com › articles › s41409/022/01726-2

   28 maj 2022 · Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children. Joseph R. Wells, Guolian Kang, Ali Y. Suliman, Ying Li, Salem Akel, Brandon Triplett & Ashok...

6. ashpublications.org › hematology › articleHow to approach thrombocytopenia - American Society of Hematology

   ashpublications.org › hematology › article

   • Zapisane w pamięci cache

   8 gru 2012 · A low platelet count can result from a wide range of conditions and may be determined by multiple mechanisms. Prompt recognition of the cause of thrombocytopenia is often crucial for the correct management of patients, as in acute promyelocytic leukemia, heparin-induced thrombocytopenia, or thrombotic thrombocytopenic purpura/hemolytic uremic ...

7. www.thelancet.com › journals › lanhaeImmune cytopenia after allogeneic haematopoietic stem-cell ...

   www.thelancet.com › journals › lanhae

   Allogeneic haematopoietic stem-cell transplantation (HSCT) is an established treatment for malignant and non-malignant disorders and is often the only option to treat the disease. 1 Besides the well known complications of allogeneic HSCT (ie, organ toxicity, infections, graft-versus-host disease [GVHD], and disease relapse), the emergence of ...